AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2017
Jun 7, 2017
31046_dirs_2017-06-06_298a4628-442f-4e5f-a25e-640dd0de9066.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-06-02
Reporting Person: Utter Christine Marie (Principal Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-02 | Stock Option (Right To Buy) | $13.1 | A | 25000 | Acquired | 2027-06-02 | Common Stock (25000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5297 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right To Buy) | $490.8 | 2021-04-27 | Common Stock (74.0) | 74 | Direct |
| Stock Option (Right To Buy) | $218.4 | 2022-01-10 | Common Stock (21.0) | 21 | Direct |
| Stock Option (Right To Buy) | $10.85 | 2023-05-15 | Common Stock (1150.0) | 1150 | Direct |
| Stock Option (Right To Buy) | $27.05 | 2024-01-28 | Common Stock (3369.0) | 3369 | Direct |
| Stock Option (Right To Buy) | $40.45 | 2024-09-23 | Common Stock (4688.0) | 4688 | Direct |
| Stock Option (Right To Buy) | $51.0 | 2025-01-02 | Common Stock (17800.0) | 17800 | Direct |
| Stock Option (Right To Buy) | $30.86 | 2026-01-03 | Common Stock (11000.0) | 11000 | Direct |
| Stock Option (Right To Buy) | $11.23 | 2027-01-02 | Common Stock (12600.0) | 12600 | Direct |
Footnotes
F1: This option was granted on June 2, 2017, and vests over two years, with 50% of the shares underlying the option vesting on June 2, 2018, and an additional 12.5% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 2, 2018.
F2: Currently exercisable.
F3: This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 28, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 28, 2015.
F4: This option was granted on September 23, 2014 and vests over four years, with 25% of the shares underlying the option vested on September 23, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on December 23, 2015.
F5: This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.
F6: This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F7: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.